Medication Error Costs Us
Contents |
it as a free PDF. Contents Chapter Page of 464 Original Pages Text Pages Get This Book « Previous: 2 Overview of the Drug Development, Regulation,
Cost Of Medication Errors 2014
Distribution, and Use System Page 105 Share Cite Suggested Citation: "3 Medication cost of medication errors 2015 Errors: Incidence and Cost ." Institute of Medicine. Preventing Medication Errors: Quality Chasm Series. Washington, DC: The National Academies average cost of a medication error Press, 2007. doi:10.17226/11623. × Save Cancel 3 Medication Errors: Incidence and Cost CHAPTER SUMMARY Medication error rates are important for gauging the scope of the problem, setting priorities for prevention strategies,
Cost Of Medical Errors 2015
and measuring the impact of those strategies. This chapter summarizes the evidence base on rates of medication errors; preventable adverse drug events; and failure to prescribe medications for which the evidence supports the ability to reduce morbidity and mortality in hospital, nursing home, and ambulatory settings. An understanding of the costs of medication errors is important as well to inform decisions about the
Cost Of Medication Errors 2013
implementation of strategies designed to reduce the risk of medication errors. This chapter also summarizes the evidence base on these costs. As noted in Chapter 1, the committee’s charge encompassed developing estimates of the incidence, severity, and costs of medication errors and evaluating alternative approaches to reducing such errors in different settings. To this end, the committee commissioned papers summarizing the salient peer-reviewed literature in the areas of hospital care, nursing home care, ambulatory care, pediatric care, psychiatric care, and use of over-the-counter (OTC) and complementary and alternative medications.1 The au- 1 The authors of the papers are as follows: for hospital care, Harvey J. Murff, MD, MPH, Vanderbilt University; for nursing home care, Ginette A. Pepper, PhD, RN, FAAN, University of Utah College of Nursing; for ambulatory care, Grace M. Kuo, PharmD, MPH, Baylor Page 106 Share Cite Suggested Citation: "3 Medication Errors: Incidence and Cost ." Institute of Medicine. Preventing Medication Errors: Quality Chasm Series. Washington, DC: The National Academies Press, 2007. doi:10.17226/11623. × Save Cancel thors were asked to review this literature from the last 10 years2 (and earlier major studies if still relevant).
Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Drugs Home Drugs Drug Safety and cost of prescription errors Availability Medication Errors Medication Errors Related to Drugs Share Tweet Linkedin Pin
How Much Does A Medication Error Cost A Hospital
it More sharing options Linkedin Pin it Email Print Within the Center for Drug Evaluation and Research (CDER), the Division preventing medication errors a $21 billion opportunity of Medication Error Prevention and Analysis (DMEPA) reviews medication error reports on marketed human drugs including prescription drugs, generic drugs, and over-the-counter drugs. DMEPA uses the National Coordinating Council for Medication Error https://www.nap.edu/read/11623/chapter/6 Reporting and Prevention (NCCMERP) definition of a medication error. Specifically, a medication error is "any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product labeling, packaging, http://www.fda.gov/drugs/drugsafety/medicationerrors/ and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use."DMEPA includes a medication error prevention program staffed with healthcare professionals. Among their many duties, program staff review medication error reports sent to MedWatch, evaluate causality, and analyze the data to provide solutions to reduce the risk of medication errors to industry and others at FDA.Additionally, DMEPA prospectively reviews proprietary names, labeling, packaging, and product design prior to drug approval to help prevent medication errors.Although DMEPA encourages manufacturers to perform their due diligence when naming their drug products and we strive to avoid approving confusing proprietary names for drug products, there are cases of adverse events where a name of a marketed product is identified as a source of confusion and error. Therefore, we continue to encourage healthcare providers, patients and consumers to report all medication errors to MedWatch so that we can be made aware of potential problems related to drug names and the Agency can provide effective interventions that will minimize further errors. In some situations, changing a proprietary name while the product is marketed may be necessary to address safety issues resulting from the name confusion errors.DMEPA also works c
be down. Please try the request again. Your cache administrator is webmaster. Generated Thu, 20 Oct 2016 12:37:26 GMT by s_wx1062 (squid/3.5.20)